HomeTLX • ASX
add
Telix Pharmaceuticals Ltd
Previous close
$10.43
Day range
$9.51 - $10.89
Year range
$8.26 - $31.97
Market cap
3.26B AUD
Avg Volume
3.13M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 206.72M | 49.29% |
Operating expense | 92.02M | 27.31% |
Net income | -2.42M | -134.29% |
Net profit margin | -1.17 | -122.99% |
Earnings per share | — | — |
EBITDA | 7.09M | -48.35% |
Effective tax rate | -1,023.95% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 141.87M | -67.76% |
Total assets | 1.16B | 23.78% |
Total liabilities | 748.61M | 27.44% |
Total equity | 415.38M | — |
Shares outstanding | 338.78M | — |
Price to book | 8.48 | — |
Return on assets | 0.86% | — |
Return on capital | 1.14% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -2.42M | -134.29% |
Cash from operations | -17.52M | -942.76% |
Cash from investing | -13.53M | 51.89% |
Cash from financing | -398.00K | -100.19% |
Net change in cash | -32.64M | -118.09% |
Free cash flow | -58.12K | -101.02% |
About
Founded
2015
Website
Employees
1,152
